Paul K J D de Jonge (Paul Kjd de Jonge)

Publication Activity (10 Years)

Years Active: 2020-2021
Publications (10 Years): 2

Top Topics

Chronic Kidney Disease

High Resolution

Patient Reported Outcomes

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Jolien M R Van der Meer, Paul K J D de Jonge, Anniek B van der Waart, Alexander C Geerlings, Jurgen P Moonen, Jolanda Brummelman, Janne de Klein, Malou C Vermeulen, Ralph J A Maas, Nicolaas P M Schaap, J S Hoogstad-van Evert, Petronella B Ottevanger, Joop H Jansen, Willemijn Hobo, Harry Dolstra
CD34+ progenitor-derived NK cell and gemcitabine combination therapy increases killing of ovarian cancer cells in NOD/SCID/IL2Rgnull mice. Oncoimmunology 10 (1) (2021)
Ralph J A Maas, J S Hoogstad-van Evert, Jolien M R Van der Meer, Vera Mekers, Somayeh Rezaeifard, Alan J Korman, Paul K J D de Jonge, Jeannette Cany, Rob Woestenenk, Nicolaas P M Schaap, Leon F Massuger, Joop H Jansen, Willemijn Hobo, Harry Dolstra
TIGIT blockade enhances functionality of peritoneal NK cells with altered expression of DNAM-1/TIGIT/CD96 checkpoint molecules in ovarian cancer. Oncoimmunology 9 (1) (2020)